MAI Capital Management lifted its holdings in Globe Life Inc. (NYSE:GL – Free Report) by 7,213.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,997 shares of the company’s stock after purchasing an additional 5,915 shares during the period. MAI Capital Management’s holdings in Globe Life were worth $857,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of GL. Waddell & Associates LLC acquired a new position in Globe Life during the third quarter worth $246,000. Mufg Securities Americas Inc. boosted its stake in shares of Globe Life by 19.5% during the 3rd quarter. Mufg Securities Americas Inc. now owns 2,185 shares of the company’s stock worth $312,000 after acquiring an additional 356 shares in the last quarter. Compound Planning Inc. boosted its stake in shares of Globe Life by 8.4% during the 3rd quarter. Compound Planning Inc. now owns 1,886 shares of the company’s stock worth $270,000 after acquiring an additional 146 shares in the last quarter. Clearstead Advisors LLC increased its holdings in shares of Globe Life by 1.9% during the 3rd quarter. Clearstead Advisors LLC now owns 5,273 shares of the company’s stock valued at $754,000 after acquiring an additional 100 shares during the last quarter. Finally, Koshinski Asset Management Inc. bought a new position in shares of Globe Life in the 3rd quarter valued at approximately $489,000. 81.61% of the stock is currently owned by institutional investors.
Globe Life Price Performance
NYSE:GL opened at $145.32 on Monday. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a one year low of $109.38 and a one year high of $152.71. The company has a fifty day moving average price of $141.88 and a 200 day moving average price of $138.72. The stock has a market cap of $11.43 billion, a P/E ratio of 10.32 and a beta of 0.46.
Globe Life Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be issued a $0.33 dividend. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s payout ratio is currently 7.67%.
Key Globe Life News
Here are the key news stories impacting Globe Life this week:
- Positive Sentiment: Board raised the quarterly dividend to $0.33 (22.2% increase) and announced two new board members — supports income-focused investors and signals confidence in cash flow. GLOBE LIFE INC. DECLARES DIVIDEND AND ANNOUNCES APPOINTMENT OF TWO NEW BOARD MEMBERS
- Positive Sentiment: Wells Fargo published a positive price-forecast note on Globe Life, which can attract buyers and lend near-term support to the share price. Wells Fargo & Company Issues Positive Forecast for Globe Life (NYSE:GL) Stock Price
- Neutral Sentiment: Globe Life Field booked for an Eagles concert, which forced a local high school to reschedule prom — shows strong event demand and venue utilization but has minimal direct impact on insurance operations. Eagles concert at Globe Life Field moves Texas high school’s prom night date How an Eagles concert at Globe Life Field bumped a North Texas high school prom
- Neutral Sentiment: GL was included in a Zacks piece highlighting high-ROE stocks as resilient plays; such coverage may raise investor interest but is not a company-specific catalyst. Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
- Negative Sentiment: CEO James Matthew Darden sold 9,527 shares (~15% reduction in his reported ownership), a sizable insider sale that can spook some investors. SEC Form 4 – Darden sale
- Negative Sentiment: EVP Robert Edward Hensley sold 712 shares (~7.7% reduction in his holding), another insider sale that adds to selling pressure signals. SEC Form 4 – Hensley sale
- Negative Sentiment: TipRanks flagged Globe Life’s rising allocation to alternative assets as increasing volatility, capital strain and liquidity risk — a potential medium-term headwind for valuation if realized. Globe Life’s Growing Alternative Asset Bets Raise Volatility, Capital Strain and Liquidity Risk
Insider Buying and Selling
In related news, Director Mark A. Blinn sold 1,750 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $147.91, for a total value of $258,842.50. Following the completion of the transaction, the director directly owned 3,372 shares in the company, valued at approximately $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer owned 35,868 shares in the company, valued at $5,192,969.04. This represents a 25.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 73,868 shares of company stock worth $10,700,437. 1.97% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of equities research analysts have issued reports on GL shares. JPMorgan Chase & Co. upped their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. TD Cowen restated a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Piper Sandler reiterated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Eight research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $171.33.
Check Out Our Latest Analysis on Globe Life
Globe Life Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More
- Five stocks we like better than Globe Life
- Silver Crossed $100: Is the $500 surge next? (Join us March 4)
- America’s 1776 happening again
- Unlocked: Elon Musk’s Next Big IPO
- Silver paying 20% dividend. Plus 68% share gains
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
